WHY DIGITAL PHARMA JAPAN IS THE NUMBER-ONE PROVIDER OF CONTENT, INNOVATION, AND PRACTICAL INSIGHTS FOR THE LIFE SCIENCE MARKETING COMMUNITY IN JAPAN
It is no longer enough for a company to have specific digital teams added to a brand plan as a bolt-on. From an early stage, Regulatory, Legal, Compliance, IT, Innovation, Commercial Operations, Customer Interaction, Sales/Field Force and many other departments all need to interact with the various marketers to develop initiatives that really deliver for the customer. No matter your size/scale of operations.
This conference will profile best-in-class case studies and senior-level discussions that will allow you to leverage solutions, technologies and tactics to prepare for tomorrow. Issues include reducing costs, mastering MCM, improving uses and effectiveness of new digital marketing techniques, harnessing analytics to drive improved ROI/customer satisfaction and improving SFE.
There are some exciting potential solutions on the horizon, but still many questions being asked:
How will digital disruption transform the pharma business model?
Unlike other industries, the “Uber” of the pharma industry has yet to emerge, and the market remains ripe for digital disruption. Pharma companies are exploring how to transform through change management and new business models to better engage their customers, and streamline their operations, and stay competitive.
How can pharma leverage digital and navigate digital trends and technologies to maximize positive outcomes for patients?
Examining the adoption of digital across all industries is an important benchmarking process for pharma. Understanding how and why digital will impact healthcare and how patients can benefit is the key to developing successful and long-lasting engagement with your customer base. Therefore, identifying what a pharma company can do to address digital trends and emerging technologies is the first step in understanding what pharma companies will look like in future and preparing for this transition of your business.
How can pharma generate value from digital medicine solutions?
As pharma companies shift from implementing traditional products to connected solutions, companies are challenged to define and realize value from this new business model (e.g. revenue stream) that intelligent, digital medicine solutions require.
How can pharma engage with disruptive technologies?
AI, AR, and cognitive computing are now a reality and are being used by doctors and physicians in predictive diagnostics. If we start to advance toward diagnostics from AI on a regular basis and certain decision-making processes out of the doctors’ hands, what are the implications for pharma marketing? How will brands and marketing teams adapt to this new world?
How can we demonstrate the value of digital for pharma products?
Pharma companies are increasingly exploring the role digital can play in demonstrating value through data, analytics, and real-world evidence.
How will pharma adapt to successfully engage HCPs?
As HCPs evolve in their engagement with patients and how they manage their practice, pharma companies will have to transform their HCP-engagement approach.
We will explore these questions and more. Reserve your seat for the inaugural Digital Pharma Japan conference to join the conversation and contribute to the advancement of digital health to improve patient outcomes and customer centricity!